Pacific Edge Launches Cxbladder Triage
08th December 2014

Dunedin-based Pacific Edge has released today the second product in its suite of diagnostic tests for the detection and management of bladder cancer. Read More

Cxbladder User Program research agreement signed with Kaiser Permanente Southern California
27th August 2014

Pacific Edge Ltd has signed an agreement with Southern California Permanente Medical Group (SCPMG) to research its User Program to evaluate its bladder cancer technology Cxbladder within the clinical settings of Kaiser Permanente’s health care network. Read More

Cxbladder testing service e-commerce site goes live in New Zealand
29th July 2014

All New Zealand residents and healthcare professionals can today access the Cxbladder cancer detection technology developed by Dunedin-based Pacific Edge with the ‘go live’ of an e-commerce platform. Read More

Pacific Edge to launch New Zealand e-commerce site for bladder cancer testing service
09th July 2014

Cancer diagnostic developer and service provider Pacific Edge is set to launch an e-commerce platform later this month to make its Cxbladder technology available to all New Zealanders from the convenience of their home. Read More

Pacific Edge signs Cxbladder agreement with MultiPlan
25th May 2014

Pacific Edge announced today that it has entered into a contractual agreement with MultiPlan, Inc. for diagnostics laboratory testing. The agreement includes Pacific Edge’s participation in the MultiPlan, PHCS and PHCS Savility Networks. Read More

Callaghan Innovation Growth Grant accelerates Cxbladder development
27th February 2014

Pacific Edge is delighted to have the support of Callaghan Innovation to further accelerate the development of its molecular cancer detection technology. Read More

BOP and Lakes Urologists adopt Cxbladder
11th February 2014

Patients presenting with symptoms of bladder cancer and those under surveillance of bladder cancer in the Bay of Plenty and Lakes District Health Board regions will now be evaluated as part of their clinical program, with Pacific Edge’s non-invasive urine sampling Cxbladder Detect test. Read More

Health Innovation Hub signs commercial agreement
10th February 2014

The Health Innovation Hub (HIH) has signed a commercial agreement to engage DHBs in the adoption of Pacific Edge’s non-invasive bladder cancer detection system Cxbladder, making it accessible for nearly one out of every two New Zealanders. Read More

Cxbladder™ Boosting Confidence in Bladder Cancer Detection in the US
29th January 2014

Bladder cancer patients, survivors, and families faced with life-long surveillance of the highly recurring disease are finding reassurance in Cxbladder. Read More